These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. LeRoy EC; Black C; Fleischmajer R; Jablonska S; Krieg T; Medsger TA; Rowell N; Wollheim F J Rheumatol; 1988 Feb; 15(2):202-5. PubMed ID: 3361530 [No Abstract] [Full Text] [Related]
6. Criteria for the classification of early systemic sclerosis. LeRoy EC; Medsger TA J Rheumatol; 2001 Jul; 28(7):1573-6. PubMed ID: 11469464 [TBL] [Abstract][Full Text] [Related]
7. [Clinico-immunological characteristics of the course of systemic scleroderma]. Musaev SK; Speranskiĭ AI Ter Arkh; 1984; 56(5):42-5. PubMed ID: 6611599 [No Abstract] [Full Text] [Related]
8. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Poirier TJ; Rankin GB Am J Gastroenterol; 1972 Jul; 58(1):30-44. PubMed ID: 4537959 [No Abstract] [Full Text] [Related]
9. Case control study of antibodies to ENA in progressive systemic sclerosis patients. Furst DE; Obrodovic M; Barnett EV; Clements PJ; Paulus HE J Rheumatol; 1984 Jun; 11(3):298-305. PubMed ID: 6610753 [TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of scleroderma and pseudoscleroderma. Fabri M; Hunzelmann N J Dtsch Dermatol Ges; 2007 Nov; 5(11):977-84. PubMed ID: 17976138 [TBL] [Abstract][Full Text] [Related]
11. The spectrum of scleroderma. LeRoy EC; Lomeo R Hosp Pract (Off Ed); 1989 Oct; 24(10A):33-42 contd. PubMed ID: 2509491 [No Abstract] [Full Text] [Related]
12. Antibody pattern and other criteria for diagnosis and classification in PSS. Burgos-Vargas R; Martínez-Cordero E; Reyes-López PA; Herrera-Esparza R J Rheumatol; 1988 Jan; 15(1):153-4. PubMed ID: 3258382 [No Abstract] [Full Text] [Related]
13. [General practice-relevant diagnostic and differential diagnostic aspects of collagen diseases. Sclerodermia progressiva, dermatomyositis and periarteritis nodosa]. Apostoloff E; Sönnichsen N Z Arztl Fortbild (Jena); 1987; 81(8):388-91. PubMed ID: 2887075 [No Abstract] [Full Text] [Related]
14. [Antinuclear antibodies as early diagnostic criteria of developing collagen disease in quartz dust exposure--a case report]. Mehlhorn J; Conrad K; Frank KH; Ziegler H; Harzbecker K; Ullmann L; Lüthke K Z Gesamte Inn Med; 1990 Mar; 45(3):68-71. PubMed ID: 2159677 [TBL] [Abstract][Full Text] [Related]
16. HLA in systemic scleroderma (PSS) and familial scleroderma. Sasaki T; Denpo K; Ono H; Nakajima H J Dermatol; 1991 Jan; 18(1):18-24. PubMed ID: 2050902 [TBL] [Abstract][Full Text] [Related]
17. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles. Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440 [TBL] [Abstract][Full Text] [Related]